Community acquired urinary tract infection: Etiology and bacterial susceptibility

Acta Cirurgica Brasileira

Volumn 18, Issue SUPPL. 5, 2003, Pages 33-36

  Neto, José Anastácio Dias ^a   Martins, Antonio Carlos Pereira ^a   Da Silva, Leonardo Dias Magalhães ^a   Tiraboschi, Ricardo Brianezi ^a   Domingos, André Luis Alonso ^a   Cologna, Adauto José ^a   Paschoalin, Edson Luis ^b   Tucci Jr , Silvio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FMRP USP ^*

Author keywords

Antibiotic; Bacteria; Community; Infection; Susceptibility; Urinary tract

Indexed keywords

EID: 55449110754     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/s0102-86502003001200012     Document Type: Article

References (18)

1. th ed. 2002; 515-602.
2. Mobley HLT. Virulence of two primary uropathogens. ASM News 2000; 66:403-10.
3. Magree JT, Pritchard EL, Fitzgerald KA. On behalf of the Welsh Antibiotic Study Group. Antibiotic prescribing and antibiotic resistance in the community practice: retrospective study, 1996-8. BMJ 1999; 319:1239-40.
4. Grunberg RN. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J Antimicrob Chemother 1994;33: 1-8
5. Raz R, Kov N, et al. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J 2000; 2: 426-9.
6. Gales AC. Evaluation of the antimicrobial susceptibility profile and mechanisms of resistance to quinolones among Escherichia coli isolates collected from patients with urinary tract infection in the Latin America. São Paulo;s.n; 2001.121p. ilus.tab.
7. Perugini MRE, Vidotto MC. Clinical characteristics and virulence in Escherichia coli urinary tract infection. Semina 1992;13: 22-9.
8. Bertelli MSB, Cambruzzi C. Bacterial resistance evaluation to quinolones in urinary infection treatment. Rev Cient AMECS 1996; 5: 32-6.
9. Guzzela J, Fuentefria SR. Quinolones: sensibility and resistance in vitro against enterobacteria and pseudomonas isolated of patients with urinary infection. Rev Med Hosp São Vicente de Paulo 1991; 3: 11-4.
10. Feier CAK, Barbosa GL, Fuentefria SR. Resistência bacteriana em infecções urinárias hospitalares e comunitárias. Rev med Hosp São Vicente de Paulo 1991; 3: 29-32.
11. Kass EHFM. Assymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69: 56-64.
12. Prais D, Strussberg R. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 2003; 88: 215-8.
13. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003; 88: 444-5.
14. Andrews JM. The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemother 2001; 48(suppl S1): 29-45.
15. Mangioarotti P, Pizzini C, Fanos V. Antibiotic prophylaxis in children with relapsing urinary tract infections. J Chemother 2000; 12: 115-23.
16. Kristiansen B-E. Uriveispatogene bakterier. Frekvens og resistensforhold. Tidsskr Nor Laegeforen 1983; 103: 1684-6.
17. Vromen M, van der Ven AJ. Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrob Chemother 1999; 44: 113-6.
18. Zhanel GG, KarlowskyJA, Harding GKM. A Canadian national surveillance study of urinary tract isolates from out patients: Comparison of the activities of trimethoprim-sulfametaxazole, ampicilin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicr Agents Chemother 2000; 44: 1089-92.